Neurosurgery for Parkinson's Disease

 

 Buy Article Permissions and Reprints

ABSTRACT

Medical therapy for Parkinson's disease (PD) often becomes inadequate over several years. Disability increases despite maximal medical management and many patients develop motor fluctuations and dyskinesia. In addition, medications provide good control of tremor in only 50% of cases. In appropriately selected cases, surgical therapies for PD provide benefit for medically refractory symptoms. Recent advances have provided a greater array of surgical options. Unilateral thalamotomy and thalamic stimulation are considered safe and effective procedures to treat contralateral tremor. Pallidotomy and pallidal stimulation primarily reduce contralateral dyskinesia, with lesser effects on bradykinesia and rigidity. Studies indicate that subthalamic nucleus (STN) stimulation improves ``off'' period function, decreases ``off'' time, and lessens dyskinesia. Fetal cell transplantation remains experimental, and studies are underway to evaluate the safety and efficacy of porcine fetal cell and human retinal pigment epithelial cell transplantation. This chapter reviews the history of surgical procedures for PD, describes current procedures, and offers a look into the future of neurosurgical options for PD.

REFERENCES

• 1 Koller W C, Busenbark K, Minor K, and the ET Study Group. Relationship of essential tremor to other movement disorders: report on 678 patients.  Ann Neurol . 1994;  35 717-723
  CrossrefPubMedGoogle Scholar
• 2 Lang A E, Lozano A M. Parkinson's disease.  N Engl J Med . 1998;  339 1130-1143
  CrossrefPubMedGoogle Scholar
• 3 Das K, Benzil D L, Rovit R. Irving S. Cooper (1922-1985): a pioneer in functional neurosurgery.  J Neurosurg . 1988;  89 865-873
  PubMedGoogle Scholar
• 4 Meyers H R. The modification of alternating tremors, rigidity, and festination by surgery of the basal ganglia.  Nerv Ment Dis . 1942;  21 602-665
  PubMedGoogle Scholar
• 5 Meyers H R. Surgical procedure for postencephalitic tremor, with notes on the physiology of the premotor fibers.  Arch Neurol Psychiatry . 1940;  44 455-457
  PubMedGoogle Scholar
• 6 Bucy P C. Cortical extirpation in the treatment of involuntary movements.  Res Nerv Ment Dis Proc . 1942;  21 551-595
  PubMedGoogle Scholar
• 7 Cooper I S, Bravo G J. Implications of a five-year study of 700 basal ganglia operations.  Neurology . 1958;  8 344-346
  PubMedGoogle Scholar
• 8 Cooper I S, Bravo G J, Riklan M. Chemopallidectomy and chemothalamectomy for parkinsonism.  Geriatrics . 1958;  13 127-144
  PubMedGoogle Scholar
• 9 Svennilson E, Torvik A, Lowe R, Leksell L. Treatment of parkinsonism by stereotactic thermolesions in the pallidal region.  Acta Psychiatr Scand . 1960;  35 358-377
  PubMedGoogle Scholar
• 10 Mundinger F, Riechert T. Esgelnisse der sterotaktischen Hirnoperationen bei extrapyramidalen Bewegungsstrorungen auf Grund postoperativer und Langzeituntersuchungen.  Dtsch Z Nervenheilkd . 1961;  182 5442-5576
  PubMedGoogle Scholar
• 11 Cooper I S. Parkinsonism: Its Medical and Surgical Therapy.  Springfield, IL: Charles C Thomas; 1961
  Google Scholar
• 12 Spiegel E A, Wycis H T. Stereoencephalotomy: Part 2. Clinical and Physiological Applications New York: Grune & Stratton; 1962
  Google Scholar
• 13 Cooper I S. Surgical treatment of parkinsonism.  Annu Rev Med . 1965;  16 309-330
  CrossrefPubMedGoogle Scholar
• 14 Spiegel E A, Wycis H T, Marks M. Stereotactic apparatus for operation on the human brain.  Science . 1947;  106 349-350
  CrossrefPubMedGoogle Scholar
• 15 Spiegel E A, Wycis H T. Ansotomy in paralysis agitans.  Arch Neurol Psychiatry . 1954;  71 598-614
  PubMedGoogle Scholar
• 16 Laitenen L V, Bergenheim A T, Hariz M I. Leskell's posteroventral pallidotomy in the treatment of Parkinson's disease.  J Neurosurg . 1992;  76 53-61
  PubMedGoogle Scholar
• 17 Laitenen L V, Bergenheim A T, Hariz M I. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms.  Stereotact Funct Neurosurg . 1992;  58 14-21
  PubMedGoogle Scholar
• 18 Selby G. Stereotactic surgery for the relief of Parkinson's disease: Part I. A critical review.  J Neurol Sci . 1967;  5 315-342
  CrossrefPubMedGoogle Scholar
• 19 Tasker R R. Surgical aspects: symposium on extrapyramidal disease.  Appl Ther . 1967;  9 454-462
  PubMedGoogle Scholar
• 20 Tasker R R, Siqueira J, Hawrylyshyn P. What happened to VIM thalamotomy for Parkinson's disease?.  Appl Neurophysiol . 1983;  46 68-83
  PubMedGoogle Scholar
• 21 Kelly P J, Ahlskog J E, Goerss S J. Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording in patients with Parkinson's disease.  Mayo Clin Proc . 1987;  62 655-664
  PubMedGoogle Scholar
• 22 Matsumoto K, Schichijo F, Fukami T. Long-term follow-up review cases of Parkinson's disease after unilateral or bilateral thalamotomy.  J Neurosurg . 1984;  60 1033-1044
  PubMedGoogle Scholar
• 23 Miyamoto T, Bekku H, Moriyama E. Present role of stereotactic thalamotomy for parkinsonism: retrospective analysis of operative results and thalamic lesions in computed tomograms.  Appl Neurophysiol . 1985;  48 294-304
  PubMedGoogle Scholar
• 24 Mundinger F. Postoperative and long-term results of 1,561 stereotactic operations in parkinsonism.  Appl Neurophysiol . 1985;  48 293
  PubMedGoogle Scholar
• 25 Narabayashi H, Maeda T, Yokochi F. Long-term follow-up results of selective VIM-thalamotomy.  J Neurosurg . 1986;  65 296-302
  PubMedGoogle Scholar
• 26 Scott R M, Brody J A, Cooper I S. The effect of thalamotomy on the progress of unilateral Parkinson's disease.  J Neurosurg . 1970;  32 286-288
  PubMedGoogle Scholar
• 27 Tasker R R. Thalamotomy.  Neurol Clin . 1990;  1 841-864
  PubMedGoogle Scholar
• 28 Riechert T. Stereotactic Brain Operations: Methods, Clinical Aspects, Indications.  Bern: Hans Huber 1980: 213-304
  Google Scholar
• 29 Linhares M N, Tasker R R. Microelectrode-guided thalamotomy for Parkinson's disease.  Neurosurgery . 2000;  46 390-398
  PubMedGoogle Scholar
• 30 Fox M W, Ahlskog J E, Kelly P J. Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients.  J Neurosurg . 1991;  75 723-730
  PubMedGoogle Scholar
• 31 Osenbach R K, Burchiel K J. Thalamotomy: indications, techniques and results. In: Lozano AM, ed. Neurosurgical Treatment of Movement Disorders Park Ridge: AANS 1998: 107-129
  Google Scholar
• 32 Diederich N, Goetz C G, Stebbins G T. Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease.  Neurology . 1992;  42 1311-1314
  PubMedGoogle Scholar
• 33 Moriyama E, Beck H, Miyamoto T. Long-term results of ventrolateral thalamotomy for patients with Parkinson's disease.  Neurol Med Chir (Tokyo) . 1999;  39 350-356
  PubMedGoogle Scholar
• 34 Laitenen L V. Thalamic targets in stereotactic treatment of Parkinson's disease.  J Neurosurg . 1966;  24 82-85
  PubMedGoogle Scholar
• 35 Lozano A, Hutchison W, Kiss Z, Tasker R, Davis K, Dostrovsky J. Methods for microelectrode-guided posteroventral pallidotomy.  J Neurosurg . 1996;  84 194-202
  PubMedGoogle Scholar
• 36 Lang A E, Duff J, Saint-Cyr J A. Posteroventral medial pallidotomy in Parkinson's disease.  J Neurol . 1999;  28-48 (28-48)
  PubMedGoogle Scholar
• 37 Laitenen L V, Bergenheim T, Hariz A L. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease.  J Neurosurg . 1992;  76 53-61
  PubMedGoogle Scholar
• 38 Dogali M, Fazzini E, Kolodny E. Stereotactic ventral pallidotomy for Parkinson's disease.  Neurology . 1995;  45 753-761
  PubMedGoogle Scholar
• 39 Lozano A M, Lang A E, Galvez-Jimenez N. Effect of Gpi pallidotomy on motor function in Parkinson's disease.  Lancet . 1995;  346 1383-1387
  CrossrefPubMedGoogle Scholar
• 40 Baron M S, Vitek J L, Bakay R AE. Treatment of advanced Parkinson's disease by posterior Gpi pallidotomy: 1-year results of a pilot study.  Ann Neurol . 1996;  40 355-366
  CrossrefPubMedGoogle Scholar
• 41 Uitti R J, Wharen R E, Turk M F. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients.  Neurology . 1997;  49 1072-1077
  PubMedGoogle Scholar
• 42 Fazzini E, Dogali M, Sterio D. Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy.  Neurology . 1997;  48 1273-1277
  PubMedGoogle Scholar
• 43 Merello M, Nouzeilles M I, Cammarotta A. Changes in the motor response to acute L-dopa challenge after unilateral microelectrode-guided posteroventral pallidotomy.  Clin Neuropharmacol . 1998;  21 135-138
  PubMedGoogle Scholar
• 44 Jankovic J, Ben-Arie L, Schwartz K. Movement and reaction times and fine coordination tasks following pallidotomy.  Mov Disord . 1999;  14 57-62
  CrossrefPubMedGoogle Scholar
• 45 Iacono R P, Shima F, Lonser R R. The results, indications and physiology of posteroventral pallidotomy for patients with Parkinson's disease.  Neurosurgery . 1995;  36 1118-1127
  PubMedGoogle Scholar
• 46 Lang A E, Lozano A M, Montgomery E. Posteroventral medial pallidotomy in advanced Parkinson's disease.  N Engl J Med . 1997;  337 1036-1042
  CrossrefPubMedGoogle Scholar
• 47 Sutton J P, Couldwell W, Lew M F. Ventroposterior medial pallidotomy on motor function in Parkinson's disease.  Neurosurgery . 1995;  36 1112-1117
  PubMedGoogle Scholar
• 48 Ondo W G, Jankovic J, Lai E C. Assessment of motor function after stereotactic pallidotomy.  Neurology . 1998;  50 266-270
  PubMedGoogle Scholar
• 49 Melnick M E, Dowling G A, Aminoff M J. Effect of pallidotomy on postural control and motor function in Parkinson's disease.  Arch Neurol . 1999;  56 1361-1365
  CrossrefPubMedGoogle Scholar
• 50 Martinez-Martin P, Valldeoriola F, Molinuevo J L. Pallidotomy and quality of life in patients with Parkinson's disease: an early study.  Mov Disord . 2000;  15 65-70
  CrossrefPubMedGoogle Scholar
• 51 Uitti R J, Wharen R E, Turk M F. Efficacy of levodopa therapy on motor function after posteroventral pallidotomy for Parkinson's disease.  Neurology . 1998;  51 1755-1757
  PubMedGoogle Scholar
• 52 Kishore A, Turnbull I M, Snow B J. Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease: six month follow-up with additional 1-year observations.  Brain . 1997;  120 729-737
  CrossrefPubMedGoogle Scholar
• 53 Koller W C, Pahwa R, Lyons K, Albanese A. Surgical treatment of Parkinson's disease.  J Neurol Sci . 1999;  167 1-10
  CrossrefPubMedGoogle Scholar
• 54 Ondo W G, Ben-Aire L, Jankovic J. Weight gain following unilateral pallidotomy in Parkinson's disease.  Acta Neurol Scand . 2000;  101 79-84
  CrossrefPubMedGoogle Scholar
• 55 Johnson K A, Cunnginton R, Bradshaw J L. Bimanual co-ordination in Parkinson's disease.  Brain . 1998;  121 743-753
  CrossrefPubMedGoogle Scholar
• 56 Schuurman P R, De Bie M A R, Speelman J D. Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients.  Mov Disord . 1997;  12 7552-7555
  PubMedGoogle Scholar
• 57 Hoehn M M, Yahr M D. Evaluation of the long term results of surgical therapy. In: Gillingham FJ, Donaldson IML, eds. Third Symposium on Parkinson's Disease London: Livingstone 1969: 274-280
  Google Scholar
• 58 Scott R, Gregory T, Hines N. Neuropsychological, neurological, and functional outcome following pallidotomy for Parkinson's disease: a consecutive series of eight simultaneous bilateral and twelve unilateral procedures.  Brain . 1998;  121 659-675
  CrossrefPubMedGoogle Scholar
• 59 Giller C A, Dewey R B, Ginsburg M I. Stereotactic pallidotomy and thalamotomy using individual variations of anatomic landmarks for localization.  Neurosurgery . 1998;  42 56-62
  PubMedGoogle Scholar
• 60 Merello M, Nouzeilles M I, Kuzis G. Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: a prospective randomized comparison.  Mov Disord . 1999;  14 50-56
  CrossrefPubMedGoogle Scholar
• 61 Siegfried J, Compte P, Meier R. Intracerebral electrode implantation system.  J Neurosurg . 1983;  59 356-359
  PubMedGoogle Scholar
• 62 Siegfried J, Rea G. Advances in neurostimulation devices. In: Plichina F, Broggi G, eds. Advanced Technology in Neurosurgery Berlin: Springer 1988: 199-207
  Google Scholar
• 63 Tasker R R, Organ L W, Hawrylshyn P. Investigation of the surgical target for alleviation of involuntary movement disorders.  Appl Neurophysiol . 1982;  45 261-274
  PubMedGoogle Scholar
• 64 Benabid A L, Pollak P, Gao D. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders.  J Neurosurg . 1996;  84 203-214
  CrossrefPubMedGoogle Scholar
• 65 Blond S, Caparros-Lefebvre D, Parker F. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus.  J Neurosurg . 1992;  77 62-68
  PubMedGoogle Scholar
• 66 Koller W, Pahwa R, Busenbark K. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.  Ann Neurol . 1997;  42 292-299
  CrossrefPubMedGoogle Scholar
• 67 Limousin P, Speelman J D, Gielsen F. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor.  J Neurol Neurosurg Psychiatry . 1999;  66 289-296
  CrossrefPubMedGoogle Scholar
• 68 Ondo W, Jankovic J, Schwartz K. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor.  Neurology . 1998;  51 1063-1069
  PubMedGoogle Scholar
• 69 Schuurman P R, Bosch D A, Bossuyt P. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor.  N Engl J Med . 2000;  342 461-468
  CrossrefPubMedGoogle Scholar
• 70 Siegfried J, Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms.  Neurosurgery . 1994;  35 1126-1130
  CrossrefPubMedGoogle Scholar
• 71 Volkman J, Sturm V, Weiss P. Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease.  Ann Neurol . 1998;  44 953-961
  CrossrefPubMedGoogle Scholar
• 72 Ghika J, Villemure J G, Fankhauser H. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review.  J Neurosurg . 1998;  89 713-718
  PubMedGoogle Scholar
• 73 Benazzouz A, Piallat B, Ni G. Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease.  Cell Transplant . 2000;  9 215-221
  PubMedGoogle Scholar
• 74 Smith Y, Parent A. Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity.  Brain Res . 1988;  453 353-356
  CrossrefPubMedGoogle Scholar
• 75 Sellal F, Hirsch E, Lisovoski F. Contralateral disappearance of parkinsonian signs after subthalamic hematoma.  Neurology . 1992;  42 255-256
  PubMedGoogle Scholar
• 76 Rodriguez M C, Obeso J A, Olanow C W. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.  Ann Neurol . 1998;  S175-S188 (S175-S188)
  PubMedGoogle Scholar
• 77 Limousin P, Krack P, Pollak P. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.  N Engl J Med . 1998;  339 1105-1111
  CrossrefPubMedGoogle Scholar
• 78 Krack P, Pollak P, Limousin P. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease.  Brain . 1998;  121 451-457
  CrossrefPubMedGoogle Scholar
• 79 Houeto J L, Damier P, Bejjani P B. Subthalamic stimulation in Parkinson's disease.  Arch Neurol . 2000;  57 461-465
  CrossrefPubMedGoogle Scholar
• 80 Moro E, Scerrati M, Romito L MA. Chronic subthalamic nucleus stimulation reduced medication requirements in Parkinson's disease.  Neurology . 1999;  53 85-90
  PubMedGoogle Scholar
• 81 Krack P, Pollak P, Limousin P. From off-period dystonia to peak-dose chorea: the clinical spectrum of varying subthalamic nucleus activity.  Brain . 1999;  122 1133-1146
  CrossrefPubMedGoogle Scholar
• 82 Kumar R, Lozano A M, Sime E. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation.  Neurology . 1999;  53 561-566
  PubMedGoogle Scholar
• 83 Krack P, Pollak P, Limousin P. Subthalamic nucleus stimulation and internal pallidal stimulation in young onset Parkinson's disease.  Brain . 1998;  121 451-457
  CrossrefPubMedGoogle Scholar
• 84 Kumar R, Lozano A M, Montgomery E. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease.  Mov Disord . 1998;  13 73-82
  PubMedGoogle Scholar
• 85 Burchiel K J, Anderson V C, Favre J. Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study.  Neurosurgery . 1999;  45 1375-1384
  CrossrefPubMedGoogle Scholar
• 86 Ardouin C, Pillon B, Peiffer E. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients.  Ann Neurol . 1999;  46 217-223
  CrossrefPubMedGoogle Scholar
• 87 Madrazo I, Drucker-Colin R, Diaz V. Open microsurgical autograft of adrenal medulla to right caudate nucleus in two patients with intractable Parkinson's disease.  N Engl J Med . 1987;  316 831-834
  PubMedGoogle Scholar
• 88 Ahlskog J E, Kelly P I, van Heerden A J. Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies.  Mayo Clin Proc . 1990;  65 305-328
  PubMedGoogle Scholar
• 89 Apuzzo J L, Neal H, Waters C H. Utilization of unilateral and bilateral stereotactically placed adrenomedullary-striatal autografts in parkinsonian humans: rationale, techniques and observations.  Neurosurgery . 1990;  26 746-757
  PubMedGoogle Scholar
• 90 Koller W C, Waxman M, Morantz R. Adrenal neural transplants in Parkinson's disease.  Adv Neurol . 1990;  53 559-565
  PubMedGoogle Scholar
• 91 Olanow C W, Koller W C, Goetz C G. Autologous transplantation of adrenal medulla in Parkinson's disease.  Arch Neurol . 1990;  47 1286-1289
  PubMedGoogle Scholar
• 92 Goetz C G, Stebbins G T, Klawans H L. United Parkinson Foundation neurotransplantation registry on adrenal medullary transplant: presurgical, and 1- and 2-year follow-up.  Neurology . 1991;  41 1719-1722
  PubMedGoogle Scholar
• 93 Jankovic J, Grossman R, Goodman C. Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease.  Neurology . 1989;  39 1227-1234
  PubMedGoogle Scholar
• 94 Frank F, Sturiale C, Gaist C. Adrenal medulla autograft in a human brain for Parkinson's disease.  Acta Neurochir (Wien) . 1988;  94 162-163
  CrossrefPubMedGoogle Scholar
• 95 Hurtig H, Joyce J, Sladek J R. Post-mortem analysis of adrenal medulla-to-caudate autograft in a patient with Parkinson's disease.  Ann Neurol . 1989;  25 607-614
  CrossrefPubMedGoogle Scholar
• 96 Waters C H, Itabashi H H, Apuzzo M LJ. Adrenal to caudate transplantation: post mortem study.  Mov Disord . 1990;  5 248-250
  CrossrefPubMedGoogle Scholar
• 97 Kordower J H, Cochran E, Penn R. Putative chromaffin cell survival and enhanced host derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease.  Ann Neurol . 1991;  29 405-412
  CrossrefPubMedGoogle Scholar
• 98 Hirsch E C, Duyckaerts C, Javoy-Agid F. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?.  Ann Neurol . 1990;  27 676-682
  CrossrefPubMedGoogle Scholar
• 99 Bjorklund A, Stenevi U, Schmidt R H. Intracerebral grafting of neuronal cell suspensions: I. Introduction and general methods of preparation.  Acta Physiol Scand . 1983;  522 9-18
  PubMedGoogle Scholar
• 100 Perlow M, Freed W J, Hoffer B J. Brain grafts reduce motor abnormalities produced by destruction of nigro-striatal dopamine system.  Science . 1979;  204 643-647
  PubMedGoogle Scholar
• 101 Clarkson E D, Freed C R. Development of fetal neural transplantation as a treatment for Parkinson's disease.  Life Sci . 1999;  23 2427-2437
  PubMedGoogle Scholar
• 102 Lindvall O, Rehncrona S, Gustavii N. Fetal dopamine-rich mesencephalic grafts in Parkinson's disease.  Lancet . 1988;  1483-1484
  CrossrefPubMedGoogle Scholar
• 103 Mahalick T J, Finger T E, Stromberg I. Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft-host interconnections.  J Comp Neurol . 1985;  240 60-70
  PubMedGoogle Scholar
• 104 Wuerthele S M, Freed W J, Olson L. Effects of dopamine agonists and antagonists on the electrical activity of substantia nigra neurons transplanted into the lateral ventricle of the rat.  Exp Brain Res . 1981;  44 1-10
  PubMedGoogle Scholar
• 105 Schmidt R H, Ingvar M, Lindvall O. Functional activity of substantia nigra grafts reinnervating the striatum: neurotransmitter metabolism and [¹⁴C]-2-deoxy-D-glucose autoradiography.  J Neurochem . 1982;  38 737-748
  PubMedGoogle Scholar
• 106 Brundin P, Bjorklund A. Survival, growth and function of dopaminergic neurons grafted to the brain.  Prog Brain Res . 1987;  71 293-308
  PubMedGoogle Scholar
• 107 Sladek J R, Collier T C, Haber S N. Survival and growth of fetal catecholamine neurons transplanted into the primate brain.  Brain Res Bull . 1986;  17 809-818
  CrossrefPubMedGoogle Scholar
• 108 Bakay R AE, Barrow D L, Fiandca M S. Biochemical and behavioral correction of MPTP-like syndrome by fetal transplantation.  Ann N Y Acad Sci . 1987;  495 623-640
  PubMedGoogle Scholar
• 109 Lindvall O. Update of fetal transplantation: the Swedish experience.  Mov Disord . 1998;  83-87 (83-87)
  PubMedGoogle Scholar
• 110 Lindvall O. Neural transplantation: a hope for patients with Parkinson's disease.  Neuroreport . 1997;  8 iii-x
  PubMedGoogle Scholar
• 111 Piccini P, Brooks D J, Bjorklund A. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.  Nat Neurosci . 1999;  2 1137-1140
  CrossrefPubMedGoogle Scholar
• 112 Lindvall O, Sawle G, Widner H. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.  Ann Neurol . 1994;  35 172-180
  CrossrefPubMedGoogle Scholar
• 113 Freeman T B, Olanow C W, Hauser R A. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.  Ann Neurol . 1995;  38 379-388
  CrossrefPubMedGoogle Scholar
• 114 Kordower J H, Freeman T B, Snow B A. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease.  N Engl J Med . 1995;  332 1118-1124
  CrossrefPubMedGoogle Scholar
• 115 Kordower J H, Freeman T B, Olanow C W. Neuropathology of fetal nigral grafts in patients with Parkinson's disease.  Mov Disord . 1998;  88-95 (88-95)
  PubMedGoogle Scholar
• 116 Hauser R A, Freeman T B, Snow B J. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson's disease.  Arch Neurol . 1999;  56 179-187
  CrossrefPubMedGoogle Scholar
• 117 Wenning G K, Odin P, Morrish P. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.  Ann Neurol . 1997;  42 95-107
  CrossrefPubMedGoogle Scholar
• 118 Fahn S. Double-blind controlled trial of embryonic dopaminergic tissue transplants in advanced Parkinson's disease.  Mov Disord . 2000;  M114 (M114)
  PubMedGoogle Scholar
• 119 Greenley H T, Hamm T, Johnson R. The ethical use of human embryonic tissue in medicine.  N Engl J Med . 1989;  320 1093-1096
  PubMedGoogle Scholar
• 120 Freeman T B, Wojak J, Brandeis L. Cross-species intracerebral grafting of embryonic swine dopaminergic neurons.  Prog Brain Res . 1988;  78 473-477
  PubMedGoogle Scholar
• 121 Schumacher J M, Ellias S A, Palmer E P. Transplantation of embryonic porcine mesencephalic tissue in patients with PD.  Neurology . 2000;  54 1042-1050
  PubMedGoogle Scholar
• 122 Subramanian R, Burnette B, Bakay R AE. Intrastriatal transplantation of human retinal pigmented epithelial cells attached to gelatin microcarriers (hRPE-GM) improved parkinsonian motor signs in hemiparkinsonian (HP) monkeys.  Mov Disord . 1998;  13 268
  CrossrefPubMedGoogle Scholar
• 123 Subramanian R, Bakay R AE, Cornfeldt M E. Blinded placebo-controlled trial to assess the effects of striatal transplantation of human retinal pigmented epithelial cells attached to microcarriers (hRPE-M) in parkinsonian monkeys.  Parkinsonism Relat Disord . 1999;  5 S111
  CrossrefPubMedGoogle Scholar
• 124 Chang C JG, Cornfeldt M L, Schweikert A W. Intracranial tolerability of Spheramine^TM (gelatin microcarrier-bound human retinal pigment epithelial (hRPE) cells) and gelatin microcarriers in cynomolgus monkey.  Soc Neurosci . 1999;  25 747
  PubMedGoogle Scholar